To FDA on labeling of plant-based milk alternatives and voluntary nutrient statements
GFI urges FDA to treat plant-based milks fairly and avoid any labeling scheme that would unfairly burden one class of products in the marketplace.
GFI urges FDA to treat plant-based milks fairly and avoid any labeling scheme that would unfairly burden one class of products in the marketplace.
GFI urges the Departments to adopt the Committee’s recommended “Eat Healthy Your Way” dietary pattern in the 2025-2030 DGA, which builds on previous iterations of the DGA by encouraging people to consume more plant-based proteins while allowing for greater flexibility to meet the needs of American families.
GFI asks the DGAC to consider the unique health, environmental, and societal benefits of alternative proteins that make it inappropriate to classify them with other UPFs.
GFI highlights plant-based meats and milks as a way to include more plant-based foods in the new Dietary Guidelines. Learn more about the benefits of a plant-based diet.
GFI’s comment discusses the role labels serve on plant-based dairy products. Learn why FDA should not restrict plant-based dairy’s clear labels.
GFI’s comment requests FDA to clarify the role of standards of identity. Learn how flexible standards support innovation and consumer choice.
GFI advocates for more plant-based foods to be credited under the Child Nutrition Programs. Learn why doing so is necessary to meet all dietary preferences.